Falchuk Steven MD - Newark, Delaware 19711

Falchuk Steven MD is categorized under Doctors in Newark, DE .

Business Name: Falchuk Steven MD
Contact Person: Steven Falchuk
Address: Helen Graham Cancer Center, Newark, Delaware 19711
Phone Number: (302) 731-7782
Website Address: rhopa.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Joshua Kalin Md - Newark, DE 19711
Papastavros' Associates Med - Newark, DE 19711
Summerton Susan MD - Newark, DE 19711
Mansoory Majid MD - Newark, DE 19711
Namey George MD - Newark, DE 19711
Lawless Stephen J MD - Newark, DE 19711
Goodman Ronald M MD - Newark, DE 19711
Friedlin F Jeffrey MD - Newark, DE 19711
Mcallister II John D MD - Newark, DE 19711
Murphy James A MD - Newark, DE 19711
Sachdev Sheelmohan MD - Newark, DE 19711
Walker Jason D MD - Newark, DE 19711
Dellose Steven M MD - Newark, DE 19711
Narun Lawrence MD - Newark, DE 19711
Doyle Timothy F M DO - Newark, DE 19711
Ritter James M MD - Newark, DE 19711
Leviton Michael MD - Newark, DE 19711
Caulfield Marie B MD - Newark, DE 19711
Stencler-Kirif Kathy MD - Newark, DE 19711
Dhanjani Vanita MD - Newark, DE 19711

The company Falchuk Steven MD provides B2C services in the form of Doctors from its single location in Delaware. 1 to 4 employees work for Falchuk Steven MD, and the business now earns $500.000 to $999.999 per annum.

Falchuk Steven MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Falchuk Steven MD, please call Steven Falchuk with the phone number (302) 731-7782 or visit its single location at Helen Graham Cancer Center in Newark, Delaware 19711.

The location of the single location can also be found using the coordinates 39.70105,-75.73804. Read more details about this business on the webpage rhopa.com or follow the company’s social media accounts, on Twitter and on Facebook.